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ABSTRACT 27 
Purpose: To examine the effects of transcorneal freezing using a new cryoprobe 28 
designed for corneal endothelial surgery.  29 
Methods: A freezing console employing nitrous oxide as a cryogen was used to cool a 30 
series of different cryoprobe tip designs made of silver for high thermal conductivity. 31 
In vitro studies were conducted on 426 porcine corneas, followed by preliminary in vivo 32 
investigations on three rabbit corneas. 33 
Results: The corneal epithelium was destroyed by transcorneal freezing, as expected, 34 
however, the epithelial basement membrane remained intact. Reproducible endothelial 35 
damage was optimally achieved using a 3.4 mm diameter cryoprobe with a concave tip 36 
profile. Stromal edema was seen in the pre-Descemet’s area 24 hrs post- freeze injury, 37 
but this had resolved by 10 days post-freeze. A normal collagen fibril structure was seen 38 
1 month post-freeze, concurrent with endothelial cell repopulation. 39 
Conclusions: Transcorneal corneal freezing induces transient posterior stromal edema 40 
and some residual deep stromal haze, but leaves the epithelial basement membrane 41 
intact, which is likely to be important for corneal re-epithelialization. Localized 42 
destruction of the endothelial monolayer was achieved in a consistent manner with a 3.4 43 
mm diameter/concave profile cryoprobe, and represents a potentially useful approach to 44 
remove dysfunctional corneal endothelial cells from corneas with endothelial 45 
dysfunction.46 
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INTRODUCTION 47 
Corneal transparency is maintained in the healthy eye by a monolayer of endothelial 48 
cells on the inner surface of the cornea. Even though human corneal endothelial cells 49 
do not possess the capacity for proliferation in vivo, the endothelium as a whole has a 50 
functional reserve to cope with cell loss via the spreading and enlargement of cells 51 
adjacent to those lost [1,2]. Excessive endothelial loss and deterioration caused by eye 52 
pathologies such as Fuchs' endothelial corneal dystrophy (FECD), however, lead to 53 
corneal edema, clouding and eventually loss of vision. FECD is a progressive 54 
degenerative disorder that is a major indication for corneal transplant surgery. Surgical 55 
intervention in the form of a full-thickness penetrating keratoplasty — or more commonly 56 
nowadays a posterior lamellar graft — are the main treatment options. But, despite the 57 
success of corneal graft surgery some questions about the long-term survival of the 58 
donor tissue [3], and the recurring problem of sufficient tissue availability remains. 59 
These limitations have led researchers to seek potential alternatives to corneal 60 
transplantation to treat corneal endothelial dysfunction. 61 
 62 
One promising route involves the use of selective inhibitors of the Rho kinase pathway. 63 
The so-called ROCK inhibitors regulate the actin cytoskeleton and influence vital cell 64 
activities such as motility, proliferation, and apoptosis [4]. Owing to their demonstrable 65 
value numerous studies have been conducted in recent years which focus on the effect 66 
of ROCK inhibitors on corneal endothelial cells both in vivo and ex vivo [5–9]. One 67 
approach involves transcorneal freezing to damage corneal endothelial cells in the 68 
central portion of the cornea in patients with FECD followed by the topical delivery of a 69 
ROCK inhibitor, Y27632, in the form of eye drops to encourage peripheral endothelial 70 
cells that had been unaffected by the freeze injury to repopulate the central zone of the 71 
corneal endothelium [10–12]. Freeze damage is achieved by application of a cold probe 72 
to the corneal surface. Another approach involves cell injection therapy whereby 73 
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cultivated human corneal endothelial cells are injected into the anterior chamber of eyes 74 
with FECD in a suspension that includes Y27632 ROCK inhibitor [13]. This agent has 75 
also been tested in the form of eye drops as a long-term pharmacological treatment for 76 
bullous keratopathy [14]. 77 
 78 
A small series of first-in-man surgeries to test the concept of transcorneal freezing 79 
followed by short-term ROCK inhibitor eye drop application for the treatment of FECD 80 
was conducted a few years ago and showed promise [10–12]. In this approach the tip of 81 
a stainless steel rod, 2 mm in diameter, was immersed in liquid nitrogen at −196°C 82 
before being applied to the surface of the central cornea for an arbitrarily chosen time of 83 
15 sec. The assumption was that central corneal endothelial cells located underneath 84 
the cold-rod applicator would be destroyed by freeze injury, although this could not be 85 
directly confirmed in the human subjects because the cloudy FECD corneas did not 86 
allow a view of the endothelium by specular microscopy. The freezing of corneal tissue 87 
has also been used as a modality to induce an injury to facilitate basic research into 88 
corneal wound healing [15–28]. If corneal freezing is to be used in a clinical setting, 89 
however (either for the destruction of diseased cells in the central endothelium prior to 90 
ROCK inhibitor eye drop application for FECD as described above, or to pre-treat the 91 
cornea prior to targeted drug delivery to combat conditions such as fungal keratitis) we 92 
contend that it needs to be achieved in a more sophisticated, reliable and reproducible 93 
manner than that achieved with an immersion-cooled steel rod. Here, we report the 94 
development and validation of a new cryoprobe based on the expansion of nitrous oxide 95 
as a cryogen, and its effect, in vitro and in vivo, on the corneal epithelium, stroma, and 96 
endothelium. 97 
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MATERIALS AND METHODS 98 
Cryoprobe Development 99 
 100 
A console that uses nitrous oxide as a cryogen was manufactured in conjunction with a 101 
series of cryoprobes with newly-designed tips, some of which matched the cornea’s 102 
curvature (Fig. 1). This prototype project was carried out by Coronet Medical 103 
Technologies Ltd, the ophthalmic arm of Network Medical Products Ltd. Enclosed gas 104 
expanded within the tip and was recycled therein, achieving a low temperature based 105 
on the Joule/Thomson effect. The tip of the cryoprobe, used to contact the corneal 106 
surface, was circular around the probe’s main axis and a number of designs were 107 
tested. Probe tips were 1.8 mm, 2.4 mm or 3.4 mm in diameter and were manufactured 108 
from silver for high thermal conductivity. Larger diameter probe tips were not considered 109 
because of the option of multiple surface freeze placements should a wider area of the 110 
cornea need to be treated. Probes either had a flat surface profile or a concave one with 111 
a radius of curvature of 8 mm. For ease of use a foot-switch was incorporated into the 112 
design, which initiates cooling at the cryoprobe tip and maintains the reduced 113 
temperature throughout the whole time it is depressed. The foot-switch is linked to a 114 
timer on the main console that provides a visual output of freezing time plus an audible 115 
signal (with a mute option) at 1 sec intervals when the foot-switch is depressed. 116 
Freezing temperature at the probe tip (−50ºC) is reached within 2 sec of depressing of 117 
the foot-switch; after release ambient room temperature is achieved within seconds. 118 
The hand-held cryoprobe has an ergonomic angled design to allow easy application to 119 
the corneal surface (Fig. 1). Probes should be thoroughly cleaned, inspected and 120 
autoclaved prior to use. 121 
 
 
 6 
122 
Figure 1.  123 
The transcorneal freezing machine attached to a cylinder of medical grade nitrous oxide 124 
(the cryogen), which comprises a main console with a monitor screen that illustrates 125 
freeze time, cryogen levels and readiness for freeze plus interchangeable probe tips 126 
and a footswitch (not shown). Inset: the 3.4 mm diameter concave probe tip 127 
manufactured from silver for high thermal conductivity. 128 
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 129 
Transcorneal Freezing in vitro 130 
 131 
The porcine cornea is comparable to that of the human cornea in terms of its structure 132 
and its overall dimensions and the pig eye is thus often used for practice by trainee 133 
corneal surgeons. The central corneal thickness in adult pigs is usually around 660 μm 134 
[29,30], which approximates a representative measurement of edematous corneal 135 
thickness in individuals with FECD [31,32]. Porcine eyes, therefore, were well suited for 136 
our investigations, and intact eyeballs, including extraocular muscles, were obtained 137 
soon after slaughter at a local abattoir (W. T. Maddock, Kembery Meats, Maesteg, 138 
Wales, UK). These were brought to the laboratory on ice and experiments were begun 139 
within 2–3 h of death. When the eyes arrived at the home laboratory, ultrasound 140 
measurements of central corneal thickness were made with a Tomey SP-100 141 
pachymeter (Erlangen, Germany), which revealed that the corneas had thickened 142 
(~1000 μm) postmortem compared to published values [31,32]. Consequently, eyes 143 
were placed in a humidified incubator (Brinsea Octagon 100, Egg Incubator, Sandford, 144 
UK) at 45ºC for 30–45 min to reverse the postmortem swelling and attain a thickness 145 
similar to what might be expected in humans with FECD. In total 426 porcine eyes were 146 
used for the in vitro experiments in which the corneal thickness ranged from 483 µm to 147 
831 µm owing to differences in eye  size and likely differential post-mortem swelling and 148 
de-swelling. 149 
 150 
Immediately after an eye was removed from the humidified incubator its central corneal 151 
thickness was recorded as an average of eight measurements. The cryoprobe tip was 152 
then applied to the corneal surface and cooling activated by pressing the foot-switch to 153 
control the flow of nitrous oxide gas. Freezing times of 3, 5, 9 and 13 sec were tested, 154 
allowing an additional 2 sec for the freezing temperature to be reached in all cases 155 
(thus, a 3-sec freeze required for a 5-sec application and foot-switch depression). The 156 
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cornea was then carefully excised at the limbus after which staining solutions of 157 
0.2% alizarin red (~1 ml) and 0.25% trypan blue were applied sequentially to the 158 
endothelial surface for 60–90 sec each to identify dead cells. The stains were then 159 
gently washed off using approximately 5 ml of 0.9% sodium chloride buffer solution, 160 
after which digital images of the corneal endothelial surface were captured on a Zeiss 161 
Stemi 1000 light microscope (Carl Zeiss, Jena, Germany). A successful freeze injury 162 
was deemed to have occurred when a clear circular wound area was seen. The 163 
endothelial wound area in each corneal image was manually traced and calculated 164 
using Image J software (http://imagej.nih.gov/ij/). Magnification was calibrated for each 165 
set of experiments using the image of an eyepiece graticule. Averages of three 166 
measurements were calculated and data were further collated using Microsoft Excel 167 
software (Microsoft Corp., Redmond, WA, USA). 168 
 169 
Statistical Analysis 170 
 171 
Statistical analyses were carried out operating IBM SPSS Statistics software (Version 172 
23.0, IBM Corporation, New York, USA). Spearman’s rank order correlation test was run 173 
to determine the relationship between central corneal thickness and endothelial wound 174 
areas induced by the freezing. 175 
 176 
Scanning Electron Microscopy 177 
 178 
To investigate the endothelial damage morphologically four treated corneas were 179 
examined by scanning electron microscopy (SEM). Immediately after excision, the 180 
corneas were fixed in 2.5% glutaraldehyde, 2% paraformaldehyde in 0.1 M sodium 181 
cacodylate buffer, pH 7.3, for at least 2 h. Samples were then washed in PBS followed 182 
by the gradual dehydration through a graded ethanol series (from 50% to 100% in 183 
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30 min steps), after which the ethanol was replaced by hexamethyldisilazane for 20 min 184 
to minimize the shrinkage of the specimens. After drying, the corneas were placed on 185 
stubs (Agar Scientific, Stansted, UK) and sputter coated with gold (Edwards S150 186 
sputter coater, Edwards High Vacuum Co. International, Wilmington, USA) to allow 187 
imaging in a JEOL JSM 5600 scanning electron microscope (JEOL Company, Tokyo, 188 
Japan) operating with a beam acceleration voltage of 15.0 kV. 189 
 190 
Transcorneal Freezing in vivo 191 
 192 
Three adult New Zealand White rabbits were used to investigate corneal recovery after 193 
transcorneal freezing. At all stages animals were treated in accordance with the ARVO 194 
Statement for the Use of Animals in Ophthalmic and Vision Research and the research 195 
was approved by the IRB of Doshisha University. As reported later, the 3.4-mm concave 196 
cryoprobe was found to be the most effective in inducing endothelial damage in the 197 
porcine eye in vitro, but owing to the thinner cornea of the rabbit the 2.4-mm concave 198 
cryoprobe was chosen for the in vivo transcorneal freezing experiments. 199 
 200 
Under general anesthesia, a 2.4-mm probe was applied to the corneal surface of the 201 
rabbit eyes for total of 5 sec. The contralateral eye was used as a control. Transcorneal 202 
freezing did not induce any severe general adverse effects. After 24 h, 10 days and 203 
1 month of treatment, the anterior segment of each eye was assessed by the use of a 204 
slit-lamp microscope and the rabbits were then euthanized. Corneal thickness was 205 
determined by the use of an ultrasound pachymeter (SP-2000; Tomey, Nagoya, Japan), 206 
and the mean of eight measured values was calculated. Intraocular pressure was 207 
measured by the use of a Tonovet tonometer (292000; KRUUSE, Langeskov, 208 
Denmark). Transmission electron microscopy (TEM) was conducted, as described 209 
below, on corneas of rabbits that were euthanized at 24 h and 1 month time-points after 210 
transcorneal freezing. 211 
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 212 
Transmission Electron Microscopy 213 
 214 
Rabbit corneas were examined by TEM 24 h and 1 month post-freeze conducted in 215 
Doshisha University, Japan. Briefly, after animals were euthanized, corneas were 216 
excised at the limbus and fixed in 2.5% glutaraldehyde and 2% paraformaldehyde in 217 
0.1 M Sörensen buffer (pH 7.2—7.4) overnight at 4ºC. Samples in fresh fixative were 218 
then express shipped to the UK. Full-thickness dissected portions of corneas were then 219 
subjected to alcohol dehydration and resin infiltration, after which they were embedded 220 
in epoxy resin (Araldyte CY212 resin, TAAB Laboratories, England, UK). Ultrathin 221 
sections were stained with uranyl acetate and lead citrate and examined on a JEOL 222 
1010 microscope operating at 80 kV (JEOL Company, Tokyo, Japan).  223 
RESULTS 224 
 225 
In vitro Transcorneal Freezing  226 
 227 
Initial experiments into the degree of endothelial damage caused by transcorneal 228 
freezing induced by four different types of cryoprobe tip — i.e. 1.8 mm diameter/flat 229 
profile, 2.4 mm diameter/flat profile, 2.4 mm diameter/concave profile, and 3.4 mm 230 
diameter/concave profile — revealed that the time of contact with the corneal surface 231 
did not affect the area of endothelial damage, with freezing times of 3, 5, 9, and 13 sec 232 
tested (data not shown). Based on this outcome, a freezing time of 3 sec was chosen 233 
for all the in vitro experiments described herein. It also became apparent during the 234 
initial investigations that the probe tip had to be in contact with the corneal surface 235 
before the foot-switch was depressed to initiate cooling. If the probe tip was cooled in air 236 
prior to being brought into contact with the cornea, no appreciable endothelial damage 237 
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was seen, no matter how long, up to 15 sec, the probe remained in contact with the 238 
cornea.  239 
 240 
Light microscopy of the endothelial surfaces of post-freeze, trypan blue-stained corneas 241 
indicated the area of cell damage caused by the four different probes used in these 242 
experiments. Representative images of 426 technical replicates denoting the typical 243 
extent of endothelial damage are shown in Fig. 2, with examples of what were 244 
considered to be successful or unsuccessful freeze injuries. A successful freeze injury 245 
was defined as one that resulted in a well-delineated circular area of cell damage. An 246 
unsuccessful freeze injury, on the other hand, was considered to have occurred either 247 
when there was no evidence of any cell damage or when the area of damage was 248 
irregular. Based on these criteria only 14 of 102 eyes (14%) treated with the 1.8 mm 249 
diameter/flat profile probe were judged to have been successfully wounded, whereas 78 250 
of 108 (72%) treated with the larger (i.e. 2.4 mm diameter) flat profile probe contained 251 
successful endothelial injuries. A similar number of eyes exhibited corneal endothelial 252 
freeze damage – i.e. 76 eyes of 108 (70%) – when the 2.4 mm diameter cryoprobe with 253 
a concave profile was used. Our data clearly indicated, however, that the 3.4 mm 254 
diameter/concave profile cryoprobe induced the most consistent endothelial damage 255 
with 90 eyes of 108 (83%) being successfully wounded in a reproducible manner 256 
(Table 1). 257 
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Figure 2.  260 
Representative images of corneal endothelial freeze-injury on pig eyes ex vivo induced 261 
by 3 sec freeze with four different cryoprobe tips and assessed by trypan blue staining. 262 
The thickness of each cornea is indicated on each panel (±SD) based on eight 263 
pachymetry readings. The area of cell damage is seen via the blue stain and successful 264 
and non/less successful freeze injuries are shown in the left and right colums, 265 
respectively. Freezing with the 1.8 mm diameter/flat profile probe only rarely resulted in 266 
a reproducible wound (A, B). Endothelial freeze injury was more reliably achieved with 267 
2.4 mm diameter probe tips with flat or concave profiles (C-F), but the optimal result and 268 
best consistency was achieved using the 3.4 mm diameter/concave profile cryoprobe 269 
(G, H). Scale bar, 3 mm. See table 1, also. 270 
 271 
To quantify the extent of endothelial cell damage we used Image J to manually trace 272 
around each wound deemed to have been successfully created (i.e. n=258 of 426 273 
technical replicates). The area of each wound was calculated, which, unsurprisingly, 274 
disclosed that larger probe tips led to more extensive endothelial damage (Table 1). All 275 
of the 426 corneas examined were subjected to multiple pachymetry measurements 276 
immediately prior to transcorneal freezing. This revealed that the average corneal 277 
thickness was 649 μm (± 61 µm SD), which is a fair representative value for corneal 278 
edema in humans with endothelial dysfunction [31,32]. Moreover, when the corneal 279 
thickness of individual corneas was taken into account, a statistical Spearman’s rank 280 
order correlation test identified that there was a weak relationship between central 281 
corneal thickness and endothelial damage when treated with the smallest and largest 282 
probes (1.8 mm  diameter (r=–0.208, n=102, p=0.408) and 3.4 mm diameter (r=–0.258, 283 
n=108, p=0.007), but a stronger relationship using the 2.4 mm diameter probe tips with 284 
concave and flat profiles (r=–0.433, n=108, p<0.001; 2.4-mm (r=–0.466, n=108, 285 
p<0.001, respectively) (Table 1). 286 
 287 
 288 
 289 
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Table 1.  290 
Data summary of transcorneal freezing for 3 sec on porcine eyes. 291 
Probe Tip 
(mm)/Profile  
No. 
Eyes 
No. Eyes 
with 
Successful 
Freeze (%) 
Mean/SD 
Damaged 
Area 
(mm2) 
Mean 
Diameter 
(mm) 
Mean/SD 
Corneal 
Thickness 
(nm) 
1.8/Flat 102 14 (14) 0.79/0.4 1.0   642/64 
2.4/Flat 108 78 (72) 2.12/1.0 1.6 650/71 
2.4/Concave 108 76 (70) 2.29/1.0 1.6 645/87 
3.4/Concave 108 90 (83) 6.91/1.9 2.9 654/59 
 292 
 293 
To provide higher resolution information as to the status of the cells after freeze injury in 294 
the in vitro pig eye model we conducted a series of SEM studies (Fig. 3). This indicated 295 
that the corneal endothelial monolayer was severely disrupted in the central portion of 296 
the cornea beneath the site of the cryoprobe injury. Injured cells tended to become 297 
damaged and/or disassociated from each other, whereas non-injured cells adjacent to 298 
the area of damage exhibited classic hexagonal endothelial cell morphology. 299 
Interestingly, there appeared to be two transition zones between healthy non-frozen 300 
cells and the more central damaged ones. The immediate transition at the inner edge of 301 
the morphologically normal cells was fairly abrupt, and in some cases this was on a µm-302 
scale (Fig. 3E, F, G). More centrally there was evidence of cellular dissociation 303 
(Fig. 3E), and also total removal of large areas of frozen endothelial cells, exposing a 304 
bare Descemet’s membrane (Fig. 3D, H). 305 
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Figure 3.  307 
SEM of the endothelium of transcorneally frozen pig corneas. (A) An untreated pig 308 
cornea with cell boarders in white showing a characteristic hexagonal mosaic. The 309 
outline if the cell nucleus is evident as a slightly lighter area within each cell. Scale bar, 310 
10µm. (B) A representative image taken at the same magnification of the freeze 311 
damaged area after treatment with a 2.4 mm diameter/concave profile tip, illustrating 312 
severe damage to endothelial cells by freezing. Scale bar, 10µm. (C, D) Lower 313 
magnification images of endothelial freeze injured wounds showing circular areas of 314 
endothelial cell damage including some endothelial debridement, exposing Descemet’s 315 
membrane (C: 2.4 mm diameter/concave profile cryoprobe (scale bar, 200µm); D: 3.4 316 
mm diameter/concave profile cryoprobe (scale bar, 500µm)). As expected the larger 317 
probe induces more widespread damage (see Table 1 also). (E-H) Transition zones 318 
between unfrozen endothelial cells and those that were destroyed by freeze injury are 319 
often sharp (E and G; same area, but different magnification (scale bars,10 μm, apart  320 
from G which is 50 µm). 321 
 322 
To investigate endothelial healing after transcorneal freeze a small number of rabbit 323 
corneas were studied. For these investigations, a 2.4 mm diameter/concave profile 324 
cryoprobe was used rather than the 3.4-mm concave one owing to the relative thinness 325 
(approximately 350–400 μm) of the rabbit cornea compared to that of the pig 326 
(approximately 660 μm [29][30]). This revealed that one day after a 3 sec surface freeze 327 
the rabbit cornea had become significantly edematous, with its thickness approximately 328 
twice the normal value (Fig. 4A). The central corneal thickness returned to normal 329 
values by day 7, and this was maintained up to one month post-freeze (Fig. 4C). Slit-330 
lamp images showed some evidence of corneal haze at the level of the posterior stroma 331 
or Descemet’s membrane at 10 days and 1 month (Figs. 4B and 4C). 332 
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Figure 4.  334 
Effects of a 3 sec freeze on rabbit cornea in vivo using the 2.4 mm diameter/concave 335 
profile cryoprobe tip. (A) 24 hrs after freeze, central corneal thickness (CCT) is 336 
increased considerably (769 μm) compared to before freeze (383 µm) and the cornea is 337 
hazy, indicative of corneal endothelial damage, as well as epithelial and stromal cell 338 
damage. (B) 10 days after a freeze injury (in a different animal) CCT was at normal 339 
levels. (C) This was the case also, 1 month after treatment. (B, C) Some corneal 340 
haziness at the level of the posterior stroma or Descemet’s membrane is evident at 10 341 
days and 1 month.  342 
 343 
TEM examinations of rabbit corneas 24 hrs after freeze indicated that the corneal 344 
epithelium peripheral to the wound area was structurally normal, with typical epithelial 345 
stratification, cell-cell contact and surface microvilli (Fig. 5A). As expected, the corneal 346 
epithelium was severely damaged in the central freeze-injured region of the cornea, with 347 
considerable cellular vacuolation and membrane destruction (Fig. 5B). However, it was 348 
clear that the epithelial basement membrane remained intact, which presumably is 349 
important to aid subsequent epithelial resurfacing of the wound area. In the deep 350 
stroma, increased collagen fibril spacing accompanied by disorder in the fibril 351 
arrangement, was sometimes observed focally 24 hrs post-freeze (Fig. 5C), but this had 352 
resolved by the 1-month timepoint at which time the stromal architecture appeared 353 
normal throughout the cornea (Fig. 5D). These structural matrix changes likely 354 
contribute to the increased corneal thickness and opacity seen at 24 hrs (Fig. 4A). 355 
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 356 
Figure 5.  357 
TEM of the corneal epithelium (Ep), epithelial basement membrane (BM), and stroma 358 
(St) following a 3 sec trans-corneal freeze injury using 2.4 mm diameter/concave profile 359 
cryoprobe on rabbit cornea in vivo. (A) The peripheral epithelium away from the wound 360 
zone, 24 hrs after the cryoprobe was applied, appeared morphologically normal. 361 
Arrowheads indicate to microvilli on apical surface of epithelial cells. (B) Intact 362 
basement membrane is observed in the central freeze-injured area 24 hrs post-freeze. 363 
(C) After 24 hrs freeze-injury occasional focal regions of stromal matrix disruption were 364 
evident in the cornea, manifesting as tissue regions with increased spacing between 365 
collagen fibrils. (D) One month after the freezing, throughout the cornea, the spacing 366 
between collagen fibril appeared normal. Scale bars, 1 μm (A, B) and 0.5 μm (C, D). 367 
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 368 
Just as with the corneal epithelium, the corneal endothelium in the periphery of the 369 
cornea away from the region of the tissue under the surface wound zone remained 370 
unaffected 24 hrs after transcorneal freeze of the central rabbit cornea (Fig. 6A). The 371 
endothelium more centrally, however, began to exhibit clear signs of damage (Fig. 6B). 372 
The central endothelium was often fully debrided with a bare Descemet’s membrane 373 
that showed no apparent structural changes (Fig. 6C). One month after freeze the 374 
central corneal endothelium had re-attained its normal character, although occasionally 375 
fibrous tissue deposition between Descemet’s membrane and the recovered 376 
endothelium was observed (Fig. 6D), which perhaps contributes to the deep stromal 377 
haze seen at this time (Fig. 4C). 378 
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Figure 6.  380 
TEM of corneal epithelium following a 3 sec trans-corneal freeze injury using 2.4 mm 381 
diameter/concave profile cryoprobe on rabbit cornea in vivo. (A) An endothelial cell 382 
(Endo) at 24 hrs post-freeze in a region peripheral to the freeze injured area appeared 383 
morphologically normal, with normal organelles and nucleus (n). It adhered to 384 
Descemet’s membrane (DM). (B) Closer to the region below the cryoprobe surface 385 
application there were clear signs of cell damage including the destruction of the cell 386 
membrane, whilst even more centrally (C) the cell damage was more extreme revealing 387 
a bare Descemet’s membrane, consistent with the SEM analysis (Fig 3). (D) One month 388 
after the transcorneal freezing was performed, the central region of the inner cornea 389 
contained fairly normal endothelial cells that were sometimes accompanied by 390 
extracellular matrix material (white arrowheads) in the area posterior to Descemet's 391 
membrane. Scale bars, 2 μm. 392 
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DISCUSSION 393 
 394 
A number of investigative surgical procedures, which utilize the selective ROCK 395 
inhibitor, Y27632, to combat FECD and bullous keratopathy are under investigation, 396 
including cell-injection therapy [10–14]. However, one alternative approach for FECD, 397 
especially in its early stage, involves freezing the central cornea using a cold probe to 398 
damage corneal endothelial cells beneath the surface contact area; this is then followed 399 
by the short-term delivery, for one week, of Y27632 in eye drop formulation [10–12]. In 400 
these surgeries freezing was achieved by touching the corneal surface with a stainless 401 
steel rod, which had been immersed in liquid nitrogen. An arbitrary freezing time of 402 
15 sec was chosen for these experiments, along with a 2-mm diameter for the steel rod. 403 
Encouragingly, the outcomes of these surgeries showed some promise, especially if the 404 
extent of the corneal endothelial dysfunction was not widespread, but if the approach is 405 
to be adopted more widely by the ophthalmic community the corneal freeze would 406 
probably need to be achieved in a more reliable manner and with more knowledge of 407 
the nature and extent of the freeze damage. 408 
 409 
Historically, and up to the present day corneal freezing has been carried out by a variety 410 
of methods, most of which use it to induce an experimental injury for research into 411 
corneal wound healing [15–17,28]. Freezing studies tend either to employ a brass rod or 412 
dowel, which had been immersed in liquid nitrogen [17–21] or similarly cooled steel 413 
ones [22,23]. Retinal cryoprobes have also been used in investigational studies of 414 
transcorneal freezing [24,33]. Here, we report the design and manufacture of a corneal 415 
cryoprobe that uses circulating nitrous oxide as a cryogen and report the type of freeze 416 
damage it induces. 417 
 418 
Typically, the tips of cryoprobes that use high-pressure gas as a cryogen are made of 419 
stainless steel owing to the need to contain high-pressure gas safely. In our design, 420 
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however, the use of stainless steel would have resulted in a freeze that started in the 421 
center of the tip and thereafter spread, albeit quickly, to its outer circumference at a 422 
speed which relies on the thermal conductivity of the metal. To achieve a more uniform 423 
cooling across the probe tip we manufactured a cryoprobe tip out of silver, which has a 424 
higher thermal conductivity than that of steel. The benefit of this design feature is that 425 
the diameter of the freeze in the cornea is decoupled from the depth of the freeze. 426 
Cooling in this design is based on the expansion and internal recycling of nitrous oxide 427 
inside the cryoprobe tip. At the point of its transition from liquid to gas nitrous oxide 428 
exists at a temperature of –88.5ºC, and this transition, which occurs inside our probe tip, 429 
of course, rapidly cools it. Owing to thermal conductivity within the whole probe and 430 
thermal loss at ambient room temperature, an equilibrium is reached, which in our 431 
design means that the temperature at the outer surface of the probe tip reaches –50ºC. 432 
 433 
The response of a cell to freezing is explained by Fraunfelder in his comprehensive 434 
review of corneal cryotherapy, the main mechanisms of cell damage being a piercing of 435 
the cell membrane by ice crystals or the creation of a sizeable osmotic imbalance 436 
between the inside and outside of the cell because of the removal of liquid water into 437 
the ice crystals [34]. Armitage also describes, from the other side of the coin, how 438 
careful freezing using time-mediated freeze-thaw protocols accompanied by the use of 439 
cryoprotectants can lead to cell survival [35]. The freezing we achieve here can 440 
probably be thought of as being fairly conservative in terms of the rate of endothelial 441 
cooling, but our current observations clearly indicate that sufficient levels of endothelial 442 
damage are achieved after a single freeze treatment. Experiments that applied 443 
additional treatments to the same surface location did not enhance the extent of the 444 
freeze injury (data not shown). We also found that if the foot-switch was depressed to 445 
initiate cooling of the probe tip before it was brought into contact with the corneal 446 
surface then no appreciable endothelial freeze damage was seen, even if the cryoprobe 447 
was kept in contact with the cornea for periods up to 15 sec. It is not immediately clear 448 
why this is the case, but perhaps frosting of the probe tip when it is cooled in the moist 449 
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air could contribute to this. This likely lack of frosting also might help facilitate the easy 450 
release of the probe tip from the corneal surface after the foot-switch is released, which 451 
we found to happen within a second or two of the cryogen circulation being suspended.  452 
 453 
In the experiments described here the central corneal epithelium was destroyed by the 454 
application of the cryoprobe, as we would expect. But, it is of potential importance that 455 
the corneal epithelial basement membrane remains intact as seen by TEM. The lack of 456 
epithelial basement membrane damage will presumably aid the epithelial resurfacing of 457 
the debrided epithelial area. Fibril arrangement changes are also apparent focally in the 458 
stromal matrix after the in vivo rabbit freeze-injury, but these are transient and the 459 
increased collagen fibril separation and disorganization which are seen 24 hrs after the 460 
treatment subsequently decrease as corneal thickness reduces. The obvious conclusion 461 
is that the recovering endothelium is mostly responsible. Of course, the in vivo healing 462 
studies reported here do not reflect the situation in the human cornea because of the 463 
different behavior of the endothelial cells and their limited replicative ability in humans. 464 
TEM also discloses the presence of fibrotic extracellular matrix tissue in the region of 465 
Descemet’s membrane one month after freeze injury (Fig. 6D). This might contribute to 466 
the deep stromal haze seen at this time, although a potential contribution to light scatter 467 
by freeze-damaged keratocytes cannot be discounted. 468 
 469 
As mentioned the use of ROCK inhibitors has aided the recovery of the corneal 470 
endothelium in situations where diseased corneal endothelial cells have been scraped 471 
away surgically [13] or frozen with a cooled steel rod applied to the corneal surface [10–472 
12]. A report by Balachandran et al. [36] and Shah and associates also suggests that 473 
corneal endothelial cells can repopulate in FECD patients after damage alone [37–39]. 474 
The data presented here show that endothelial cells can be functionally damaged 475 
and/or removed by the application of a cryogenic cold probe and that this can be done 476 
in a targeted and reproducible manner with cell damage restricted to the area below the 477 
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surface contact. Of course, the transcorneal freezing technique is unlikely to induce any 478 
significant change to the guttae which exist in FECD and their continued presence will 479 
conceivably hinder the reformation of a normal endothelial layer.  Nevertheless, cell 480 
damage can be achieved through use of a silver 3.4 mm diameter cryoprobe with a 481 
concave profile, which was discovered to be the optimal design of the cryoprobes tested 482 
in the experiments described here. It thus has the potential to rapidly and reliably induce 483 
damage to the human corneal endothelium via transcorneal freezing, leaving the 484 
epithelial basement membrane intact. This has the potential to be used prior to the 485 
application of ROCK inhibitors to the eye in the form of eye drops [10–12] or as slow-486 
release chemicals from thin films [40] to aid the recovery of corneal endothelial function.   487 
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